Origin Agritech Strengthens Gene Editing Platform through Patent License Agreement with Shunfeng BioTech
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 10 2025
0mins
Source: PRnewswire
Patent License Agreement: Origin Agritech Ltd. has signed a patent license agreement with Shandong Shunfeng Biotechnology Co., Ltd. for the Cas-SF01 gene editing tool, enhancing its capabilities in corn breeding and gene editing technologies.
Research Collaboration: The partnership builds on previous work with China Agricultural University, focusing on key regulatory genes in corn, leading to the development of edited corn induction lines that optimize plant architecture for improved yields.
Commercialization and Biosafety: Origin Agritech is advancing the biosafety assessment for its edited corn lines, aiming for regulatory approval within 1-2 years to facilitate the commercialization of its gene editing innovations.
Strategic Goals: The collaboration supports Origin's objectives in biosafety compliance, direct breeding resources, and establishing a core technology foundation for its "Smart Plant Architecture" corn breeding program, contributing to agricultural advancements in China.
Get Free Real-Time Notifications for Any Stock
Monitor tickers like SEED with instant alerts to capture every critical market movement.
Sign up for free to build your custom watchlist and receive professional-grade stock notifications.
Analyst Views on SEED
About SEED
Origin Agritech Ltd is a holding company mainly engaged in agricultural biotechnology. The Company specializes in crop seed breeding and genetic improvement, seed production, processing, distribution and related technical services. The Company and its subsidiaries are primarily engaged in corn seed development and distribution business as well as research on crop genetic improvement breeding technology. The Company's products include corn seeds, nutritionally enhanced corn (NEC), soybean seeds, rapeseed seeds and rice seeds. The Company has a breeding research platform in the country, including research centers, breeding stations, winter breeding bases, and others. The Company mainly conducts its business in domestic and overseas markets.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Origin Agritech to Announce FY2025 Financial Results on January 30
- Financial Results Announcement: Origin Agritech will release its fiscal year 2025 financial results on January 30, 2026, reflecting the company's ongoing commitment to transparency and investor communication.
- Conference Call Details: The company will host a conference call on February 2, 2026, at 8 a.m. ET, led by CEO Weibin Yan and CFO Patrick Cheng, aimed at providing in-depth discussions on financial results and business updates with investors.
- Investor Engagement: Investors can submit questions via email by January 29, demonstrating the company's emphasis on investor feedback and enhancing investor relations.
- Technological Innovation Background: Since its founding in 1997, Origin Agritech has made significant strides in crop seed biotechnology, being the first to receive a Bio-Safety Certificate for transgenic corn from China's Ministry of Agriculture, showcasing its leadership in the industry.
Continue Reading
Origin Agritech to Announce FY 2025 Financial Results
- Earnings Announcement Schedule: Origin Agritech is set to release its FY 2025 financial results on January 30, 2026, and will discuss these results in a conference call on February 2, which may influence the company's stock price.
- Conference Participation Details: The call will be led by CEO Weibin Yan and CFO Patrick Cheng, allowing investors to submit questions via email by January 29, enhancing engagement with the investment community.
- Technological Innovation Background: Founded in 1997, Origin Agritech has made significant strides in crop seed biotechnology, with its phytase corn being the first transgenic corn to receive a Bio-Safety Certificate from China's Ministry of Agriculture, showcasing the company's leadership in the industry.
- Future Outlook Statements: The company's forward-looking statements highlight uncertainties regarding future business and financial performance, urging investors to consider market changes and potential risks, thereby ensuring transparency and compliance.
Continue Reading